About Cohera Medical

Cohera Medical received the 2010 Frost & Sullivan New Product Innovation of the Year Award. Click image above to read more.

Cohera Medical awarded 2011 Life Sciences Company of the Year and Patrick Daly named Pittsburgh CEO of the Year. Click image above to read more.

Company Overview

Our Commitment

At Cohera Medical, Inc.® we are committed to creating surgical adhesives that improve patient care and quality of life – for all surgical procedures, applications and specialties.

Our Technology

Cohera Medical is planning to enter the European market with its first product offering, TissuGlu® Surgical Adhesive, which Cohera’s researchers designed to help plastic and aesthetic surgeons reduce the need for surgical drains in abdominoplasty (tummy tuck) and other plastic surgery procedures. TissuGlu Surgical Adhesive is resorbable,
biocompatible for internal use, uses no human or animal based ingredients
and forms a strong bond between tissues.

Our Future

Cohera Medical’s scientific leaders continue to explore new clinical applications for the company’s patented adhesive technologies, including applications in colorectal, orthopaedic and general surgery.

Disclaimer: TissuGlu Surgical Adhesive received European CE Mark in 2011. Currently, TissuGlu Surgical Adhesive is not approved for use in the United States or any other country outside of the EU.